Helicobacter pylori and Barrett's Esophagus
Author Information
Author(s): Angel Ferrández, Rafael Benito, Juan Arenas, María Asunción García-González, Federico Sopeña, Javier Alcedo, Javier Ortego, Ricardo Sainz, Angel Lanas
Primary Institution: Hospital Clínico Lozano Blesa, Zaragoza, Spain
Hypothesis
Infection with cagA+ Helicobacter pylori strains protects against the development of Barrett's esophagus.
Conclusion
Neither H. pylori infection nor H. pylori infection by CagA+ strains reduce the risk of Barrett's esophagus in a population with high prevalence of H. pylori infection.
Supporting Evidence
- H. pylori prevalence was higher in patients with Barrett's esophagus than in controls (87.5% vs. 74.6%).
- Increasing age was associated with a higher prevalence of H. pylori (p < 0.05).
- The prevalence of CagA+ H. pylori serology was similar in patients with Barrett's esophagus and controls (64.4% vs. 54.5%).
- Logistic regression identified alcohol and H. pylori infection as independent factors associated with Barrett's esophagus.
Takeaway
This study found that having a certain type of bacteria in your stomach doesn't help prevent a condition called Barrett's esophagus, which can lead to cancer.
Methodology
The study involved 104 patients with Barrett's esophagus and 213 matched controls, assessing H. pylori infection and CagA antibody status through serology.
Potential Biases
Potential selection bias due to the control group being blood donors, which may not represent the general population.
Limitations
The study relied on serology for H. pylori diagnosis, which may not be as accurate as biopsy methods.
Participant Demographics
104 patients with Barrett's esophagus (82 male, 22 female) and 213 matched controls.
Statistical Information
P-Value
0.013
Confidence Interval
95% CI: 1.20–4.84
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website